News

Nerve signals

Novel treatment for motor neuron disease to be trialled in humans

University of Sheffield researchers are taking part in an investigational drug trial, designed to target one of the most important genetic drivers of MND, the UNC13A protein.

A plastic model of the brain anatomy

Novel clinical trial platform could dramatically speed up search for Motor Neuron Disease treatments

A University of Sheffield researcher was one of the lead investigators into a novel trial design that could mean faster results in the race to find effective treatments for Motor Neuron Disease.
Celebrating Dr Johnathan Cooper-Knock's appointment as the first MND Association Rob Burrow Professor
Credit: MND Association

Sheffield neurologist becomes first MND Association Rob Burrow Professor

A world-leading neurologist and geneticist at the University of Sheffield has been appointed to the first Rob Burrow Professorship in Translational Neurobiology named after the late rugby league legend Rob Burrow CBE.

Architect's rendering of proposed new SITraN sister facility
Architect's rendering of proposed new SITraN sister facility. Credit: Bond Bryan Architects

University of Sheffield reaches £14m to further groundbreaking neuroscience research

Fundraising success as University of Sheffield reaches £14m to further groundbreaking neuroscience research.
3D rendering Futuristic design of Virus exploding

New research identifies more than 1,000 genes linked to severe COVID-19

Researchers from the University of Sheffield and Stanford University in the US have discovered there are specific genetic signals in people who develop severe coronavirus infection.
Neuron cell close-up view - 3d rendered image of Neuron cell on black background. SEM view interconnected neurons synapses.

New £1.2 million funding to advance development of investigational MND drug

Researchers from the University of Sheffield and early-stage biopharmaceutical company Aclipse Therapeutics have been awarded £1.2 million to support the development of an investigational motor neurone disease (MND) drug.